Will Stone

Scientists are turning up more evidence that some people may harbor a viral reservoir in the wake of COVID-19. What could that tell us about long COVID?

The drug had been fast-tracked for approval under the agency's accelerated approval program, and has been available for more than a decade, despite the drugmaker's failure to prove that it works.

Older adults and others at high risk are now able to get a second shot of the COVID-19 booster that targets omicron.

Long criticized as discriminatory, the policy has prevented many gay and bisexual men from donating blood. The Food and Drug Administration revealed a draft of its new approach on Friday.

Call it "precision waking" — the alleged ability to decide when you want to wake up and then doing so, without an alarm. If you think you can do it, you're not alone, though how is still mysterious.

The updated recommendations seek to course correct after guidelines from 2016 were criticized for harshly limiting access to needed pain medication.

Rates of new cases are declining in major cities, suggesting public health campaigns are working. But the spread

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.

Missteps and delays have hampered the U.S. effort to vaccinate people against monkeypox. Now state health officials and community members are trying to adapt to a controversial "dose sparing" plan.

Revised guidance from the Centers for Disease Control and Prevention looks to minimize COVID-19's disruption of daily life while conceding that the pandemic isn't over.